Table 2.
Multivariate analysis.
| Progression-free survival (5 years) | Overall survival (5 years) | |||||||
|---|---|---|---|---|---|---|---|---|
| Coefficient (SE) | HR (95% CI) | p value | p value (Hochberg correction) | Coefficient (SE) | HR (95% CI) | p value | p value (Hochberg correction) | |
| International prognostic score | ||||||||
| 3–7 | 1 | 1 | ||||||
| 0–2 | − 0.11 (0.30) | 0.90 (0.49–1.63) | 0.72 | 0.72 | − 0.09 (0.49) | 0.92 (0.35–2.39) | 0.86 | 0.86 |
| First line of treatment | ||||||||
| ABVD | 1 | 1 | ||||||
| BEACOPP | − 1.25 (0.39) | 0.29 (0.13–0.61) | 0.001 | 0.003 | − 1.44 (0.75) | 0.24 (0.05–1.03) | 0.05 | 0.15 |
| MTV | ||||||||
| ≥ 217 cm3 | 1 | 1 | ||||||
| < 217 cm3 | − 0.85 (0.32) | 0.43 (0.23–0.80) | 0.008 | 0.02 | − 0.91 (0.54) | 0.40 (0.14–1.15) | 0.09 | 0.18 |